Data Characteristics in this Category
Neurodegenerative diseases, such as Alzheimer's and Parkinson's, generate distinct drug safety data. Data sources include clinical trial reports, real-world evidence (RWE) databases, post-market surveillance systems (e.g., FDA Adverse Event Reporting System, FAERS), and academic literature. Data update frequencies vary: clinical trial data typically releases after study completion, while post-market surveillance systems (like FAERS) accumulate data continuously and update quarterly. Document structures are complex, containing unstructured text (e.g., patient histories, physician diagnoses, adverse event descriptions) and structured data (e.g., drug dosage, duration of use, adverse event codes). Key fields include disease progression scores (e.g., MMSE, UPDRS), cognitive function assessments, imaging indicators (e.g., MRI brain volume changes), and specific adverse events (e.g., extrapyramidal symptoms, worsening cognitive impairment). Units involve dosage (mg), time (days, months, years), scores (integers or decimals), and biomarker concentrations (pg/mL).
Constraints on "Model Integration and Configuration" from these Characteristics
The complexity of neurodegenerative drug safety data imposes specific requirements on model integration and configuration. A high proportion of unstructured text demands robust natural language processing (NLP) capabilities for information extraction and entity recognition, particularly for disease-specific symptoms and adverse event terminology. Diverse data sources lead to high heterogeneity, requiring models to handle different formats and update frequencies. For example, integrating quarterly FAERS data with irregularly published clinical research reports. The long-term nature of disease progression and adverse reactions highlights the importance of time series analysis, requiring consideration of historical data depth and time window settings during configuration. Furthermore, neurodegenerative disease diagnosis and assessment involve extensive specialized terminology and scoring systems. This necessitates that models accurately capture semantic relationships of these professional concepts during word embedding and knowledge graph construction, preventing information loss or misjudgment due to vocabulary misunderstandings. This directly impacts knowledge base construction strategies and recall accuracy.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 8000–12000 token | Neurodegenerative disease reports often contain detailed medical histories and adverse event descriptions, requiring a large context window to capture key information. |
Chunk size (Segment Length) | 800–1000 characters | Ensures each segment contains sufficient semantic information while preventing individual segments from being too long, which could impact recall efficiency. |
Similarity threshold (Similarity Threshold) | 0.78–0.85 | Balances recall and precision, filtering out irrelevant literature or reports, focusing on highly relevant content. |
Rerank result count (Reranked Return Count) | Top 15–20 items | Further optimizes results with a reranking model, ensuring users receive high-quality, highly relevant information. |
PARSE_FILE_TIMEOUT_SECONDS | 300 seconds | Processing large clinical research reports or post-market surveillance database files requires longer parsing times. |
embeddingModel | text-embedding-ada-002 or higher version | The neurodegenerative domain has specialized terminology; selecting a high-precision embedding model enhances semantic understanding. |
Three Common Mistakes
- Knowledge base query results are empty or incomplete: This occurs due to improper segmentation strategies, where critical information is split across different segments, or the similarity threshold is set too high, preventing relevant documents from being recalled.
- Model output lacks domain specificity: This happens when the model is not effectively integrated with domain-specific knowledge bases, or pre-trained models fail to adequately learn neurodegenerative disease-specific terminology and concepts during fine-tuning.
- Timeout errors occur when processing large documents: This results from
PARSE_FILE_TIMEOUT_SECONDSbeing set too short, failing to account for the complexity and file size of documents like clinical trial reports.
How to Confirm Proper Configuration
- Select a clinical report containing typical neurodegenerative drug adverse reactions, upload it to the knowledge base, and verify that the report content is accurately segmented and indexed.
- Formulate a series of complex queries regarding specific drugs and their adverse reactions in neurodegenerative diseases. Check if the model can recall highly relevant literature and data from the knowledge base, then manually assess the accuracy and completeness of the recalled results.
- Simulate user questions about specific adverse reactions (e.g., "Hallucinations in Alzheimer's patients after using Drug A"). Check if the model's answer includes professional terminology, dosage information, and relevant research conclusions from the knowledge base, and evaluate the answer's professionalism and informational value.
- Monitor parsing times in the
fastgpt.logfile to ensure that large file processing does not result inTimeoutErroror other file parsing failures.
Note: The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.